Reuters logo
BRIEF-FDA approves new treatment for adults with relapsed follicular lymphoma
September 14, 2017 / 5:05 PM / 7 days ago

BRIEF-FDA approves new treatment for adults with relapsed follicular lymphoma

Sept 14 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA approves new treatment for adults with relapsed follicular lymphoma

* Granted the approval of Aliqopa to Bayer Healthcare Pharmaceuticals, Inc​

* Granted accelerated approval to Aliqopa for treatment of adults with relapsed follicular lymphoma who have received at least 2 prior treatments Source text: (bit.ly/2xBgW98) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below